E and F). Lateral views (A, B, C, E, and F). Anterior view (D). Enlarged view of (E) (F)
(stage 29/30), p27 Xic1 is expressed throughout most of eyes shows a 3-fold increase in p27 Xic1 RNA from stage 25 to stage 35/36, followed by a reduction to the original the retina (Figures 1C and 1D) Figure 1I ). Quantitative RT-PCR from developing the amount of p27
Xic1 RNA detected at different positions in the CMZ ( Figure 1J ). In agreement with the developmental analysis above, we find a gradual increase in p27 Xic1 mRNA level from the periphery to the center of CMZ and then a sudden decrease near the end of CMZ ( Figure 1J ). Double in situ hybridizations show that X-Notch-1 is expressed at about the same peripheral eccentricity as p27
Xic1
, indicating that it is expressed at about the same time (data not shown). However, p27
is expressed more centrally (later) than cyclin D1 (Figures 1K-1M ) and more peripherally (earlier) than the proneural gene Xath5 (Figures 1N-1P) . To look at the relationship between cell division and p27
Xic1 expression, we injected stage 41 embryos with bromodeoxyuridine (BrdU) before fixation and then double-labeled them for BrdU and p27
Xic1 expression. p27 Xic1 is clearly present in dividing cells in the CMZ, but high levels of expression also extend centrally into the postmitotic retina ( Figures  1Q-1S ). These expression patterns are summarized in Figure 1T . , anti-N (nucleotides 0-393) were also made using pCS2 ϩ . for the Nucleotide Mix in the kit. 
C (F, G, and H), or mock (B and E) was injected in a blastomere of two-cell stage embryos. The effect was observed at 64-cell stage (B-D) or at stage 9 (E-H). (G and H) Enlarged views of the indicated region in (F
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